Le Lézard
Classified in: Health
Subject: PDT

From Stage-2 Hypertension to Health Innovator: Launch of Core3Vitality


Scott Fleming, founder of Core3Vitality and a former stage-2 hypertension sufferer, introduces Nitric Oxide 400, a supplement formulated to support cardiovascular health. Discover how this innovative product aims to enhance wellness naturally.

LAS VEGAS, July 1, 2024 /PRNewswire-PRWeb/ -- 1 in 2 adults in the US have high blood pressure, and if you're over 55, the odds jump to 4 in 5. Given that heart attacks are the No.1 killer of men and women around the world, often precipitated by high blood pressure, looking to lower it is a high priority for most. This is the exact reason we developed this product, says Scott Fleming, Founder of Core3Vitality and former stage-2 hypertensive sufferer.

"Nitric Oxide 400 is designed to support blood pressure, cardiovascular health and improve overall wellness" ? Scott Fleming, Founder of Core3Vitality

Nitric Oxide 400 is a PhD doctor-designed supplement formulated to target all three nitric oxide pathways, including a full 400 mg of plant-based nitrates. This education-centric, disruptive brand intends to upend and revolutionize how the antiquated supplements industry has operated for decades - putting health before profits!

The proprietary blend includes highly concentrated patented nitrate ingredients in addition to L-Citrulline Malate, CoQ10, Grape Seed Extract, and Vitamin C. It is a single, complete product designed to support and maintain healthy blood pressure, improve blood circulation throughout the entire body, reduce the risks of clots and inflammation, and revitalize youthful energy. *

Fleming explains that the company's vision and mission mean everything to him. Educating people, raising awareness, and then supporting them in their health goals is what we do, as detailed in our hero video.

Core3Vitality is not just another supplement brand; it's a movement aimed at transforming the health and wellness industry. By leveraging scientific research and natural ingredients, we provide a powerful solution for those seeking to manage their blood pressure naturally and effectively. Join us in our mission to bring health and vitality back to people's lives.

*The Food and Drug Administration has not evaluated these statements. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Core3Vitality:

Core3Vitality is a pioneering health and wellness company dedicated to transforming the supplements industry through education, innovation, and a commitment to health before profits. Founded by Scott Fleming, a former stage-2 hypertension sufferer, Core3Vitality aims to provide scientifically backed, natural solutions that enhance overall wellness. Core3Vitality products are available exclusively in the US market, bringing high-quality, effective supplements to American consumers. For more information, visit https://core3vitality.com

Media Contact

Scott Fleming, Core3 Vitality Ltd, 44 07710014621, [email protected]https://core3vitality.com

SOURCE Core3 Vitality Ltd


These press releases may also interest you

at 07:13
Throughout July, Kevin Guest, executive chairman at USANA Health Sciences , is emphasizing boosting social connections during "Social Wellness Month." Social wellness?the ability to form meaningful relationships and interact positively with...

at 07:10
The Board of Certification for Emergency Nursing (BCEN), the benchmark for nursing specialty certification across the emergency spectrum, named Maris Panjada as BCEN's new marketing and communications director following the June 28 retirement of...

at 07:05
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen...

at 07:05
Novocure announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company's...

at 07:05
AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...



News published on and distributed by: